- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
SonoSite gains Japanese distributor
Handheld ultrasound developer SonoSite continues to expand its distribution opportunities in Asia. After establishing a subsidiary in Hong Kong and a branch office in Shanghai last month to provide direct sales and support for its products to the
Handheld ultrasound developer SonoSite continues to expand its distribution opportunities in Asia. After establishing a subsidiary in Hong Kong and a branch office in Shanghai last month to provide direct sales and support for its products to the Peoples Republic of China (SCAN 9/1/99), Bothell, WA-based SonoSite has now signed an agreement with Olympus Optical for rights to distribute the ultrasound devices in Japan. Tokyo-based Olympuss Medical Products Group markets and distributes medical endoscopes, clinical analyzers, and other advanced medical equipment. With the signing of this agreement, SonoSite has finalized arrangements to sell and distribute products in more than 75 countries through international distributors.
Study Reaffirms Low Risk for csPCa with Biopsy Omission After Negative Prostate MRI
December 19th 2024In a new study involving nearly 600 biopsy-naïve men, researchers found that only 4 percent of those with negative prostate MRI had clinically significant prostate cancer after three years of active monitoring.
Study Examines Impact of Deep Learning on Fast MRI Protocols for Knee Pain
December 17th 2024Ten-minute and five-minute knee MRI exams with compressed sequences facilitated by deep learning offered nearly equivalent sensitivity and specificity as an 18-minute conventional MRI knee exam, according to research presented recently at the RSNA conference.
Can Radiomics Bolster Low-Dose CT Prognostic Assessment for High-Risk Lung Adenocarcinoma?
December 16th 2024A CT-based radiomic model offered over 10 percent higher specificity and positive predictive value for high-risk lung adenocarcinoma in comparison to a radiographic model, according to external validation testing in a recent study.
